FluQuadri Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 60mcg, 0.5mL suspension for injection Australia - English - Department of Health (Therapeutic Goods Administration)

fluquadri inactivated quadrivalent influenza vaccine (split virion), influenza virus haemagglutinin 60mcg, 0.5ml suspension for injection

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; monobasic sodium phosphate; octoxinol 9; dibasic sodium phosphate - fluquadri is indicated for active immunisation of influenza disease caused by influenza a subtype viruses and type b viruses contained in the vaccine.,fluquadri is indicated for use in adults and children 6 months and older.

INFLUVAC TETRA influenza virus haemagglutinin 0.5mL vaccine prefilled syringe with 16 mm needle, 2024 Australia - English - Department of Health (Therapeutic Goods Administration)

influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe with 16 mm needle, 2024

viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.

FluQuadri Junior Inactivated Quadrivalent Influenza Vaccine (Split Virion), Influenza virus haemagglutinin 30mcg, 0.25mL suspens Australia - English - Department of Health (Therapeutic Goods Administration)

fluquadri junior inactivated quadrivalent influenza vaccine (split virion), influenza virus haemagglutinin 30mcg, 0.25ml suspens

sanofi-aventis australia pty ltd - influenza virus haemagglutinin -

INFLUVAC TETRA influenza virus haemagglutinin 0.5mL vaccine prefilled syringe with 25 mm needle 2024 Australia - English - Department of Health (Therapeutic Goods Administration)

influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe with 25 mm needle 2024

viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.

INFLUVAC TETRA influenza virus haemagglutinin 0.5mL vaccine prefilled syringe without needle 2024 Australia - English - Department of Health (Therapeutic Goods Administration)

influvac tetra influenza virus haemagglutinin 0.5ml vaccine prefilled syringe without needle 2024

viatris pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - suspension - excipient ingredients: magnesium chloride hexahydrate; monobasic potassium phosphate; dibasic sodium phosphate dihydrate; water for injections; potassium chloride; calcium chloride dihydrate; sodium chloride - for the prevention of influenza caused by influenza virus, types a and b.,for full details regarding recommendations for influenza vaccination, please refer to the relevant national immunisation guidelines.,influvac tetra is indicated in adults and children from 6 months of age and older.

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension Australia - English - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

VAXIGRIP TETRA Inactivated Quadrivalent Influenza Vaccine (Split Virion) influenza virus haemagglutinin 60 mcg 0.5 mL suspension for injection in pre-filled syringe needle free 2024 Season Australia - English - Department of Health (Therapeutic Goods Administration)

vaxigrip tetra inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 60 mcg 0.5 ml suspension for injection in pre-filled syringe needle free 2024 season

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: sodium chloride; water for injections; potassium chloride; monobasic potassium phosphate; dibasic sodium phosphate dihydrate - vaxigrip tetra is indicated for the prevention of influenza disease caused by the two influenza a virus subtypes and the two influenza b virus types contained in the vaccine for:,- active immunisation of adults, including pregnant women, and children from 6 months of age and older,- passive protection of infant(s) from birth to less than 6 months of age following vaccination of pregnant women (see sections 4.2 dose and method of administration, 4.4 special warnings and precautions for use, 4.6 fertility, pregnancy and lactation and 5.1 pharmacodynamic properties ? clinical trials).

FLUZONE HIGH-DOSE QIV inactivated quadrivalent influenza vaccine (Split Virion) influenza virus haemagglutinin 240 mcg, suspension for injection PFS, SH2024 Season Australia - English - Department of Health (Therapeutic Goods Administration)

fluzone high-dose qiv inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 240 mcg, suspension for injection pfs, sh2024 season

sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 60 microgram - injection, suspension - excipient ingredients: octoxinol 9; monobasic sodium phosphate; water for injections; dibasic sodium phosphate; sodium chloride - fluzone high-dose quadrivalent (qiv) is indicated for active immunisation for the prevention of influenza disease. fluzone high-dose quadrivalent is indicated for use in persons 60 years of age and older., the use of fluzone high-dose quadrivalent (qiv) should be based on official recommendations., see section 5.1 clinical trials for information on the effects on influenza associated complications.

FLUZONE HIGH-DOSE inactivated trivalent influenza vaccine (Split Virion) 180mcg influenza virus haemagglutinin 0.5mL suspension Australia - English - Department of Health (Therapeutic Goods Administration)

fluzone high-dose inactivated trivalent influenza vaccine (split virion) 180mcg influenza virus haemagglutinin 0.5ml suspension

sanofi-aventis australia pty ltd - influenza virus haemagglutinin -

FLUARIX TETRA inactivated split influenza vaccine suspension for injection 0.5 mL pre-filled PRTC syringe without needle, SH2024 influenza season Australia - English - Department of Health (Therapeutic Goods Administration)

fluarix tetra inactivated split influenza vaccine suspension for injection 0.5 ml pre-filled prtc syringe without needle, sh2024 influenza season

glaxosmithkline australia pty ltd - influenza virus haemagglutinin, quantity: 15 microgram - injection, suspension - excipient ingredients: dl-alpha-tocopheryl acid succinate; potassium chloride; sodium chloride; water for injections; polysorbate 80; dibasic sodium phosphate dodecahydrate; magnesium chloride hexahydrate; octoxinol 10; monobasic potassium phosphate - fluarix tetra is a quadrivalent vaccine indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the influenza virus types a and b contained in the vaccine (see section 5.1 pharmacodynamic properties, clinical trials).,the use of fluarix tetra should be based on official recommendations.